H.C. Wainwright raised the firm’s price target on Fortress Biotech (FBIO) to $26 from $24 and keeps a Buy rating on the shares following the Q3 report.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FBIO:
- Fortress Biotech’s Q3 2024 Earnings and FDA Milestone
- Fortress Biotech Inc (FBIO) Q3 Earnings Cheat Sheet
- Fortress Biotech files to sell 6.19M shares of common stock for holders
- Biotech Alert: Searches spiking for these stocks today
- Fortress Biotech to sell 3.9M shares at $1.65 in registered direct offering